AI Summary
This article discusses the development of esterase-responsive nanoparticles containing floxuridine for targeted cancer therapy. These nanoparticles are designed to release the drug specifically in response to esterase enzymes found in cancer cells, allowing for more targeted and effective treatment. The multifunctional nanoparticles are expected to improve the efficacy of cancer therapy while minimizing side effects. The research has significant implications for the field of cancer treatment and drug delivery.